Posts Tagged ‘malalties infeccioses’

Friday May 20th, 2011

A study opens the possibility of developing a preventive vaccine against HIV / AIDS


The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment. The total number of infected people exceeds 30 million and there are about 3 million new infections per year. The best hope for reducing the incidence of AIDS (Acquired Immune Deficiency Syndrome) is a preventive vaccine.

Read the rest of this entry »

Comments Closed


Posted in:

Monday March 14th, 2011

Virtual assistance is confirmed as an effective tool in monitoring HIV patients


The Hospital Clínic of Barcelona presented today the results of the telemedicine program “Hospital VIHrtual”, coordinated by Dr. Felipe Garcia and Dr. Agata León, from the Hospital Clínic Service of Infectious Diseases directed by Dr. Josep M ª Gatell. The tool has been created by a team from the Universidad Politécnica de Madrid, led by Prof. Enrique J. Gómez and César Cáceres. Through a direct connection via a webcam, Dr. Garcia showed a virtual consultation and explained the benefits of the project, which does not replace the classic face to face visits but complements and enhances them.

Read the rest of this entry »

Comments Closed
Sunday May 17th, 2009

Gene Therapy Protects Simians Against Infection by the AIDS Virus

Dr. Eloísa Yuste, from IDIBAPS-Hospital Clínic, is one of the author of the study

A study carried out in the United States has managed to introduce into the muscle cells of macaque monkeys the DNA necessary to produce an antibody-like molecule that is effective against SIV, the virus that causes AIDS in simians. The strategy consists of injecting an adenovirus that introduces the necessary DNA sequence into the nucleus of the muscle cells of the macaques. The researcher, Eloísa Yuste is one of the authors of the study and currently works on the IDIBAPS-Hospital Clínic team led by Dr. Josep Maria Gatell, co-director of HIVACAT(*).

Read the rest of this entry »

Comments Closed